Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.
| Name: | Vertex Pharmaceuticals Inc. |
|---|---|
| Address: | 130 Waverly Street Cambridge, Massachusetts 02139-4242 |
| Phone: | (617) 444-6100 |
| Email: | NA |
| Web site: | www.vrtx.com |
| CEO: | NA |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 88,703 | 136,296 |
| Institutional | 93.67% | NA | NA |
| Change in Short Interest as of 3/15/2013 | -0.82% | ||
| Short Interest as % of Float as of 3/15/2013 | 2.54% | ||
| Number of Employees | 2,200 |
|---|---|
| Revenue per Employee | $694,110 |
| Income per Employee | $-48,651 |
| Market Capitalization (thousands) | $11,620,100 |
| Enterprise Value (thousands) | $11,299,539 |
| Auditors Opinion | Unqualified |
Officers and Directors
Jeff M Leiden, Ian F Smith, Peter Mueller, Robert Kauffman, Amit K Sachdev, Priya Singhal, Chris Wright, Christiana Stamoulis, Eric Olson, Shelley George, Stuart A Arbuckle, Bruce I Sachs, Elaine S Ullian, Terrence C Kearney, Joshua S Boger, Yuchun Lee, Margaret G McGlynn, David Altshuler, Matthew W Emmens, Wayne Joseph Riley, Paul M Silva, Kelly Lewis, Megan E Pace, Erin Emlock, Zachry Barber
